Work

Inhibition of Pd-L1 By Mpdl3280A Leads to Clinical Activity in Pts with Metastatic Urothelial Bladder Cancer (Ubc)

Year: 2014

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdu337.1

Authors: J. Bellmunt, D.P. Petrylak, T. Powles, F. Braiteh, N. Vogelzang, C. Cruz, H. Burris, J.P. Eder, G. Fine, M.S.L. Teng, X. Shen, J. Bruey, Z. Boyd, P. Hegde, D. Chen, Y. Loriot

Institutions: Dana-Farber Cancer Institute, Columbia University Irving Medical Center, St Bartholomew's Hospital, Queen Mary University of London, Barts Cancer Institute, Comprehensive Cancer Centers of Nevada, University of Nevada, Las Vegas, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Sarah Cannon, Yale Cancer Center, Genentech, Institut Gustave Roussy

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2242173225

FWCI: 1.288

Cites:

Cited by: 12

Related to: 10